GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
87 hedge funds and large institutions have $548M invested in GW Pharmaceuticals Plc American Depositary Shares in 2014 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 26 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
25% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 20
12% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 26
0% more funds holding
Funds holding: 87 → 87 (0)
14% less call options, than puts
Call options by funds: $15.9M | Put options by funds: $18.5M
16% less capital invested
Capital invested by funds: $650M → $548M (-$102M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$18.9M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$15.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.1M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$10.2M |
| 5 |
LCP
Lamond Capital Partners
San Francisco,
California
|
+$9.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$19.7M |
| 2 |
O
OrbiMed
New York
|
-$17.9M |
| 3 |
CCM
Cupps Capital Management
Chicago,
Illinois
|
-$8.1M |
| 4 |
VAM
Visium Asset Management
New York
|
-$8.02M |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$7.89M |
GWPH Hedge Fund Activity: Q4 2014 in Review
87 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q4 2014, worth a combined $548M — down 16% from $650M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new GWPH positions and 26 closed out — a net gain of 3 holders — while 25 added to existing stakes and 20 trimmed.
The largest buyer was Jennison Associates, opening a new position worth an estimated $18.9M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $19.7M sold.
- 87 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $548M of GW Pharmaceuticals Plc American Depositary Shares stock for Q4 2014, down 16% quarter-over-quarter.
- 29 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q4 2014 and 26 closed out, a net change of +3 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q4 2014 was Jennison Associates, an estimated $18.9M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q4 2014 was Farallon Capital Management, an estimated $19.7M sold.
Based on aggregated 13F filings for Q4 2014.